ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,615Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 36

$719K Total Retail Price of All Prescriptions

Rank: 9 out of 36

356 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 356 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 356 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 7,390 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 493 396 1 2
AMLODIPINE BESYLATE 478 351 2 1
LISINOPRIL 319 221 3 3
HYDROCODONE-ACETAMINOPHEN 281 196 S3 4 7
CRESTOR 270 198 5 36
NAPROXEN 269 170 6 79
OMEPRAZOLE 254 195 7 6
LEVOTHYROXINE SODIUM 241 163 8 4
HYDROCHLOROTHIAZIDE 224 145 9 9
NEXIUM 222 129 10 26
GABAPENTIN 192 133 11 10
METOPROLOL SUCCINATE 182 138 12 18
FUROSEMIDE 174 127 13 5
CARVEDILOL 170 136 14 20
NASONEX 162 111 15 142
METFORMIN HCL 161 120 16 11
LOSARTAN POTASSIUM 151 130 17 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 149 98 18 49
ATENOLOL 146 109 19 27
HYDRALAZINE HCL 144 98 20 29
JANUVIA 144 93 20 55
CYCLOBENZAPRINE HCL 138 64 R 22 77
PANTOPRAZOLE SODIUM 131 94 23 35
METOPROLOL TARTRATE 129 108 24 8
ALLOPURINOL 124 110 25 44
DONEPEZIL HCL 115 107 26 12
CILOSTAZOL 113 87 27 161
AZITHROMYCIN 112 73 28 51
NAMENDA 106 99 29 13
POTASSIUM CHLORIDE 95 54 30 15
TRAMADOL HCL 93 51 31 14
ZOLPIDEM TARTRATE 92 62 32 24
SERTRALINE HCL 84 68 33 19
GLIMEPIRIDE 79 68 34 46
ALENDRONATE SODIUM 75 62 35 34
VOLTAREN 70 57 36 118
POLYETHYLENE GLYCOL 3350 69 34 37 43
ADVAIR DISKUS 68 40 38 70
LANTUS SOLOSTAR 66 16 39 130
TAMSULOSIN HCL 64 51 40 41
WARFARIN SODIUM 62 40 41 17
ATORVASTATIN CALCIUM 62 31 41 22
METOCLOPRAMIDE HCL 61 55 43 123
GLYBURIDE 59 46 R 44 158
LANTUS 56 46 45 38
SINGULAIR 52 37 46 101
SPIRIVA 51 42 47 76
CLOPIDOGREL 50 38 48 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.